(CLOI) VanEck Trust - VanEck CLO - Ratings and Ratios
CLO, Debt, Investment Grade, U.S. Dollar, Foreign
Dividends
| Dividend Yield | 5.84% |
| Yield on Cost 5y | 7.45% |
| Yield CAGR 5y | 77.15% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 1.29% |
| Value at Risk 5%th | 2.01% |
| Relative Tail Risk | -5.49% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.38 |
| Alpha | 0.52 |
| CAGR/Max DD | 2.41 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.261 |
| Beta | 0.110 |
| Beta Downside | 0.219 |
| Drawdowns 3y | |
|---|---|
| Max DD | 3.25% |
| Mean DD | 0.08% |
| Median DD | 0.00% |
Description: CLOI VanEck Trust - VanEck CLO November 16, 2025
VanEck CLO ETF (ticker CLOI) is an actively managed, non-diversified ETF that must invest at least 80% of its assets in investment-grade tranches of collateralized loan obligations (CLOs), primarily denominated in U.S. dollars, while permitting up to 30% of net assets in foreign-currency CLO securities.
As of Q3 2024, the fund’s weighted-average CLO tranche rating sits at AA-, its weighted-average maturity is approximately 5.5 years, and the expense ratio is 0.65 %.
The primary economic drivers for CLOI are the health of the leveraged-loan market, corporate default rates, and prevailing interest-rate trends; a tighter monetary stance by the Fed tends to compress loan spreads, which can depress CLO tranche yields.
For a deeper, data-driven view of how CLOI fits into a broader credit-allocation strategy, consider exploring the analytics platform ValueRay.
What is the price of CLOI shares?
Over the past week, the price has changed by +0.23%, over one month by +0.43%, over three months by +1.30% and over the past year by +5.92%.
Is CLOI a buy, sell or hold?
What are the forecasts/targets for the CLOI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 61.2 | 15.8% |
CLOI Fundamental Data Overview November 24, 2025
Beta = 0.06
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.25b USD (1.25b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.25b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.25b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.42% (E(1.25b)/V(1.25b) * Re(6.42%) + (debt-free company))
Discount Rate = 6.42% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for CLOI ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle